PL376659A1 - Skondensowane związki heterocykliczne - Google Patents
Skondensowane związki heterocykliczneInfo
- Publication number
- PL376659A1 PL376659A1 PL376659A PL37665903A PL376659A1 PL 376659 A1 PL376659 A1 PL 376659A1 PL 376659 A PL376659 A PL 376659A PL 37665903 A PL37665903 A PL 37665903A PL 376659 A1 PL376659 A1 PL 376659A1
- Authority
- PL
- Poland
- Prior art keywords
- heterocyclic compounds
- fused heterocyclic
- fused
- compounds
- heterocyclic
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42445602P | 2002-11-06 | 2002-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376659A1 true PL376659A1 (pl) | 2006-01-09 |
Family
ID=32312811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376659A PL376659A1 (pl) | 2002-11-06 | 2003-11-06 | Skondensowane związki heterocykliczne |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7253179B2 (pl) |
| EP (1) | EP1562943A1 (pl) |
| JP (1) | JP4547266B2 (pl) |
| KR (1) | KR20050103184A (pl) |
| CN (2) | CN101134757A (pl) |
| AU (1) | AU2003285160B2 (pl) |
| BR (1) | BR0316070A (pl) |
| CA (1) | CA2505372A1 (pl) |
| EA (1) | EA009421B1 (pl) |
| IS (1) | IS7833A (pl) |
| MX (1) | MXPA05004739A (pl) |
| NO (1) | NO20052655L (pl) |
| NZ (1) | NZ540328A (pl) |
| PL (1) | PL376659A1 (pl) |
| WO (1) | WO2004043958A1 (pl) |
| ZA (1) | ZA200503654B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070135425A1 (en) * | 2001-05-04 | 2007-06-14 | Amgen Inc. | Fused heterocyclic compounds |
| US6809104B2 (en) * | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| ZA200503654B (en) * | 2002-11-06 | 2006-09-27 | Amgen Inc | Fused heterocyclic compounds |
| CA2515717A1 (en) | 2003-02-10 | 2004-08-19 | Banyu Pharmaceutical Co., Ltd. | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| DE102010025663A1 (de) * | 2010-06-30 | 2012-01-05 | Karl-Heinz Glüsenkamp | Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate |
| CA2807538A1 (en) * | 2010-08-10 | 2012-02-16 | Abbvie Inc. | Novel trpv3 modulators |
| WO2012129491A1 (en) | 2011-03-24 | 2012-09-27 | Abbott Laboratories | Trpv3 modulators |
| MX2014004979A (es) * | 2011-10-24 | 2014-10-24 | Abbvie Inc | Derivados de metanol como moduladores de trpv3. |
| CN106588812B (zh) * | 2016-12-07 | 2019-02-22 | 烟台大学 | 一种酰氯制备2，4-二取代噻唑啉类化合物的方法 |
| KR102858168B1 (ko) | 2019-01-14 | 2025-09-10 | 자이두스 라이프사이언시즈 리미티드 | 신규 치환된 설포닐우레아 유도체 |
| HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US176694A (en) * | 1876-04-25 | Improvement in screw-cutting die-stocks | ||
| US23085A (en) * | 1859-03-01 | chandler | ||
| US199549A (en) * | 1878-01-22 | Improvement in screw-propellers | ||
| JPS5825980B2 (ja) * | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | サイクリックヌクレオチドの定量法 |
| JPS63258474A (ja) | 1986-08-15 | 1988-10-25 | セドナ・ファ−マセウチカルズ・ビ−・ブイ | カルバゾ−ル、ジベンゾフラン又はジベンゾチオフェン基を含む化合物の水酸基誘導体を調製するための方法 |
| US5049655A (en) * | 1989-03-22 | 1991-09-17 | The Salk Institute For Biological Studies | Melanin-concentrating hormones |
| JP2906654B2 (ja) | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
| US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
| JP3160941B2 (ja) * | 1991-06-17 | 2001-04-25 | 東レ株式会社 | カルバゾール誘導体および免疫抑制剤 |
| KR100241662B1 (ko) * | 1991-07-05 | 2000-03-02 | 지오르지오 스치니나 | 히드로이소퀴놀린 유도체 |
| DE69332945T2 (de) | 1992-09-29 | 2004-05-19 | Toray Industries, Inc. | Indol-derivat, verfahren zu dessen herstellung und dessen medizinische anwendung |
| US5272146A (en) * | 1992-10-02 | 1993-12-21 | The United States Of America As Represented By The United States Department Of Health And Human Services | 1,2-dihydroellipticines with activity against CNS specific cancer cell lines |
| US5457208A (en) * | 1993-06-21 | 1995-10-10 | Regents Of The University Of Minnesota | Kappa opioid receptor antagonists |
| US5464841A (en) | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| US5578725A (en) | 1995-01-30 | 1996-11-26 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| US5849708A (en) * | 1995-06-06 | 1998-12-15 | Joslin Diabetes Center, Inc. | Promotion of eating behavior |
| EP0848060A3 (en) * | 1996-12-11 | 2000-02-02 | Smithkline Beecham Corporation | Novel human 11CB splice variant |
| JP4110579B2 (ja) | 1997-01-16 | 2008-07-02 | 東レ株式会社 | インドロモルヒナン誘導体および脳障害治療・予防剤 |
| US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
| WO1999028492A1 (en) | 1997-12-03 | 1999-06-10 | Smithkline Beecham Corporation | A method of finding agonist and antagonist to human 11cb splice variant |
| CA2334551A1 (en) | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
| WO2000015793A2 (en) | 1998-09-17 | 2000-03-23 | Incyte Pharmaceuticals, Inc. | Human gpcr proteins |
| GB9822158D0 (en) | 1998-10-09 | 1998-12-02 | Nycomed Imaging As | Compositions |
| AU1802000A (en) | 1998-12-28 | 2000-07-24 | Takeda Chemical Industries Ltd. | Screening method |
| US6221613B1 (en) | 1998-12-31 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| WO2000049170A1 (en) | 1999-02-18 | 2000-08-24 | Smithkline Beecham Corporation | MURINE 11cby RECEPTOR |
| CN1341123A (zh) | 1999-02-19 | 2002-03-20 | 武田药品工业株式会社 | 新型g蛋白偶联型受体蛋白及其dna |
| CA2372980A1 (en) | 1999-05-19 | 2000-11-23 | Astrazeneca Ab | Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1) |
| AU5869100A (en) | 1999-06-08 | 2000-12-28 | Regents Of The University Of California, The | Melanin concentrating hormone receptor |
| WO2001005947A1 (en) | 1999-07-14 | 2001-01-25 | Merck & Co., Inc. | Melanin-concentrating hormone receptor |
| EP1196570A2 (en) | 1999-07-26 | 2002-04-17 | Genentech, Inc. | Human polypeptides and methods for the use thereof |
| EP1196572A1 (en) | 1999-07-27 | 2002-04-17 | Smithkline Beecham Plc | Axor21, a g-protein coupled receptor |
| US7115750B1 (en) | 1999-09-20 | 2006-10-03 | Takeda Pharmaceutical Company Limited | Melanin concentrating hormone antagonist |
| AU7315800A (en) | 1999-09-20 | 2001-04-24 | Takeda Chemical Industries Ltd. | Mch antagonists |
| JP2003514549A (ja) | 1999-11-16 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | Ｇタンパク質共役受容体 |
| JP2001226269A (ja) | 2000-02-18 | 2001-08-21 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
| WO2001068706A1 (en) | 2000-03-15 | 2001-09-20 | Merck & Co., Inc. | Melanin concentrating hormone receptor chimeric and fusion proteins |
| JP2005229804A (ja) | 2000-03-24 | 2005-09-02 | Astellas Pharma Inc | 新規なメラニンコンセントレーティングホルモン受容体 |
| CA2408913A1 (en) | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
| AU7320701A (en) | 2000-07-05 | 2002-01-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| AU2001269440A1 (en) | 2000-07-05 | 2002-01-14 | Takeda Chemical Industries Ltd. | Method for screening mch receptor antagonist/agonist |
| EP1299362A4 (en) | 2000-07-05 | 2004-11-03 | Synaptic Pharma Corp | SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE |
| MXPA03000174A (es) * | 2000-07-06 | 2003-09-22 | Neurogen Corp | Ligandos de receptor de hormona concentradora de melanina. |
| CN1469876A (zh) | 2000-10-20 | 2004-01-21 | �Ʒ� | α-芳基乙醇胺及其用作β-3肾上腺素能受体激动剂的用途 |
| US20030022891A1 (en) | 2000-12-01 | 2003-01-30 | Anandan Palani | MCH antagonists and their use in the treatment of obesity |
| DE60112791T2 (de) | 2000-12-22 | 2006-06-08 | Schering Corp. | Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität |
| US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
| JP4557492B2 (ja) | 2001-03-21 | 2010-10-06 | ファーマコペイア ドラッグ ディスカバリー， インコーポレイテッド | Ｍｃｈ調節活性を有するアリール化合物およびビアリール化合物 |
| CA2443672C (en) * | 2001-04-12 | 2011-03-29 | Pharmacopeia, Inc. | Aryl and biaryl piperidines used as mch antagonists |
| CA2446351A1 (en) | 2001-05-04 | 2002-11-14 | Tularik Inc. | Fused heterocyclic compounds |
| US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| CA2448080A1 (en) | 2001-05-22 | 2002-11-28 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| CN1592739A (zh) * | 2001-11-26 | 2005-03-09 | 先灵公司 | 用于治疗肥胖和cns疾病的基于哌啶的mch拮抗剂 |
| US7160879B2 (en) * | 2002-01-10 | 2007-01-09 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| ZA200503654B (en) | 2002-11-06 | 2006-09-27 | Amgen Inc | Fused heterocyclic compounds |
-
2003
- 2003-11-06 ZA ZA200503654A patent/ZA200503654B/en unknown
- 2003-11-06 CN CNA2007101119484A patent/CN101134757A/zh active Pending
- 2003-11-06 PL PL376659A patent/PL376659A1/pl not_active Application Discontinuation
- 2003-11-06 EA EA200500770A patent/EA009421B1/ru not_active IP Right Cessation
- 2003-11-06 US US10/705,173 patent/US7253179B2/en not_active Expired - Fee Related
- 2003-11-06 CA CA002505372A patent/CA2505372A1/en not_active Abandoned
- 2003-11-06 AU AU2003285160A patent/AU2003285160B2/en not_active Ceased
- 2003-11-06 BR BR0316070-0A patent/BR0316070A/pt not_active IP Right Cessation
- 2003-11-06 MX MXPA05004739A patent/MXPA05004739A/es active IP Right Grant
- 2003-11-06 CN CNB2003801082225A patent/CN1330651C/zh not_active Expired - Fee Related
- 2003-11-06 EP EP03779483A patent/EP1562943A1/en not_active Withdrawn
- 2003-11-06 WO PCT/US2003/035543 patent/WO2004043958A1/en active Application Filing
- 2003-11-06 NZ NZ540328A patent/NZ540328A/en unknown
- 2003-11-06 JP JP2004551872A patent/JP4547266B2/ja not_active Expired - Fee Related
- 2003-11-06 KR KR1020057008174A patent/KR20050103184A/ko not_active Withdrawn
-
2005
- 2005-05-02 IS IS7833A patent/IS7833A/is unknown
- 2005-06-02 NO NO20052655A patent/NO20052655L/no not_active Application Discontinuation
-
2007
- 2007-07-26 US US11/881,805 patent/US20080058365A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ540328A (en) | 2008-02-29 |
| US7253179B2 (en) | 2007-08-07 |
| US20040147538A1 (en) | 2004-07-29 |
| JP4547266B2 (ja) | 2010-09-22 |
| MXPA05004739A (es) | 2005-08-02 |
| KR20050103184A (ko) | 2005-10-27 |
| IS7833A (is) | 2005-05-02 |
| JP2006508130A (ja) | 2006-03-09 |
| AU2003285160B2 (en) | 2009-06-04 |
| EP1562943A1 (en) | 2005-08-17 |
| EA200500770A1 (ru) | 2005-12-29 |
| AU2003285160A1 (en) | 2004-06-03 |
| CN101134757A (zh) | 2008-03-05 |
| NO20052655D0 (no) | 2005-06-02 |
| WO2004043958A1 (en) | 2004-05-27 |
| BR0316070A (pt) | 2005-09-27 |
| CA2505372A1 (en) | 2004-05-27 |
| EA009421B1 (ru) | 2007-12-28 |
| CN1735613A (zh) | 2006-02-15 |
| US20080058365A1 (en) | 2008-03-06 |
| NO20052655L (no) | 2005-07-26 |
| CN1330651C (zh) | 2007-08-08 |
| ZA200503654B (en) | 2006-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1687002A4 (en) | CONDENSED HETEROCYCLIC COMPOUNDS | |
| IL174283A0 (en) | Fused heterocyclic compounds | |
| PL377087A1 (pl) | Związki heterocykliczne | |
| PL375935A1 (pl) | Pochodne skondensowanych azolopirymidyn | |
| AU2003291310A8 (en) | Fused heterocyclic compounds and use thereof | |
| PL374544A1 (pl) | Związki imidazo-skondensowane | |
| ZA200603881B (en) | Substituted fused heterocyclic C-glycosides | |
| IL175489A0 (en) | Substituted fused heterocyclic c-glycosides | |
| IL165178A0 (en) | Novel fused imidazole derivative | |
| IL179414A0 (en) | Fused heterocyclic compound | |
| IL166650A0 (en) | New compounds | |
| AU2003264018A8 (en) | New compounds | |
| IL163894A0 (en) | New compounds | |
| IL176384A0 (en) | Novel fused pyrrolocarbazoles | |
| GB0315870D0 (en) | Heterocyclic derivatives | |
| PL378249A1 (pl) | Skondensowane pochodne furanu | |
| MY142713A (en) | Novel fused pyrrolocarbazoles | |
| EP1476425A4 (en) | Heterocyclic Aryl Sulphonamidocyclic Compounds | |
| EP1737446A4 (en) | CONDENSED HETEROCYCLIC COMPOUNDS | |
| GB0120818D0 (en) | Heterocyclic compounds | |
| HU0203976D0 (en) | New compounds | |
| PL376659A1 (pl) | Skondensowane związki heterocykliczne | |
| AU2003280578A1 (en) | Heterocyclic compounds | |
| GB0220962D0 (en) | Heterocyclic derivatives | |
| HK1080289A (en) | Fused heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |